Jiangxi Fushine Pharmaceutical Co., Ltd. (SHE:300497)
China flag China · Delayed Price · Currency is CNY
13.20
+0.01 (0.08%)
Nov 17, 2026, 3:04 PM CST

SHE:300497 Revenue

Jiangxi Fushine Pharmaceutical had revenue of 661.89M CNY in the quarter ending September 30, 2026, with 159.89% growth. This brings the company's total for the last twelve months to 1.97B, up 102.59% year-over-year. In the year 2025, Jiangxi Fushine Pharmaceutical had annual revenue of 1.18B with 0.61% growth. That makes Jiangxi Fushine Pharmaceutical the 14,702nd largest company in the world by revenue and 2,638th in China.

Revenue (ttm)
1.97B
Revenue Growth
+102.59%
P/S Ratio
3.61
Revenue / Employee
n/a
Employees
1,663
Market Cap
7.11B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Pharmaceutical Manufacturing 814.22M 68.7%
  • Lithium Battery Electrolyte Additive 368.77M 31.1%
  • CDMO 1.99M 0.2%

By Geography

Chart
  • China 943.44M 79.6%
  • Foreign 241.54M 20.4%
Fiscal year ended Dec 31, 2025 See the full SHE:300497 breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.18B7.14M0.61%
Dec 31, 20241.18B-431.82M-26.83%
Dec 31, 20231.61B-37.59M-2.28%
Jan 1, 20231.65B217.72M15.23%
Jan 1, 20221.43B-63.41M-4.25%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.